David Charles Baker - 10 Aug 2023 Form 4 Insider Report for GRI BIO, Inc. (GRI)

Role
Director
Signature
/s/ Leanne Kelly, Attorney-in-Fact
Issuer symbol
GRI
Transactions as of
10 Aug 2023
Net transactions value
+$100,001
Form type
4
Filing time
14 Aug 2023, 16:06:20 UTC
Previous filing
01 Mar 2022
Next filing
24 Jan 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $100,001 +34,483 $2.90 34,483 10 Aug 2023 Common Stock 34,483 $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant.